Related Experiment Video
Updated: Jul 23, 2025

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
A Systematic Critical Appraisal of Clinical Practice Guidelines in Heart Failure Using the AGREE II Tool
Andrew Sephien1, Denisse Camille Dayto2, Tea Reljic3
1Division of Cardiovascular Disease, Section of Advanced Heart Failure and Transplantation, University of Alabama at Birmingham, Birmingham, Alabama.
Insights
This systematic review critically appraised heart failure clinical practice guidelines (CPGs) using AGREE II. While clarity and scope were high, applicability and rigor require improvement for better patient care.
Area of Science:
- Cardiology
- Clinical Practice Guidelines
- Health Services Research
Background:
- Multiple clinical practice guidelines (CPGs) exist for heart failure management to optimize patient outcomes.
- A critical appraisal of the methodological quality of these heart failure guidelines has been lacking.
Approach:
- A systematic review was conducted to assess the methodological quality of heart failure CPGs published between January 1, 2021, and September 8, 2022.
- The Appraisal of Guidelines for Research & Evaluation II (AGREE II) instrument was used to evaluate 6 included CPGs.
- CPGs were sourced from North America, Asia, Europe, and South America.
Key Points:
- Median AGREE II scores varied significantly across domains: 100% for Scope and Purpose, Clarity of Presentation, and Editorial Independence.
- Scores for Stakeholder Involvement and Rigor of Development were 71%, while Applicability scored 43%.
- Overall assessment scores averaged 64%.
Conclusions:
- Current heart failure CPGs demonstrate high quality in scope, clarity, and independence but show variability in stakeholder involvement, rigor, and applicability.
- Standardized approaches and the AGREE II tool can enhance the methodological rigor, reporting, and practical application of future CPGs.
- Improvements are needed to ensure CPGs effectively translate to improved patient morbidity and mortality in heart failure management.
Abstract:
Multiple clinical practice guidelines (CPGs) for heart failure management have been published to provide the best practices regarding the use of foundational therapies to reduce morbidity and mortality in this patient population. However, a critical appraisal of these heart failure guidelines has not been performed. This systematic review aimed to assess the methodological quality of current CPGs in the management of patients with heart failure. A comprehensive search of EMBASE and PubMed was conducted to identify CPGs published between January 1, 2021 and September 8, 2022. Any CPGs published in the last 2 years addressing the management of heart failure were eligible for inclusion. The methodological quality of the CPGs was assessed using the AGREE II (Appraisal of Guidelines for Research & Evaluate II) instrument. The initial search yielded 3,269 citations, of which, 6 CPGs were included. A total of 2 CPGs were each published by the cardiology associations in North America and Asia and 1 each in Europe and South America. The overall median score for the AGREE II domains were 100% for scope and purpose, 71% for stakeholder involvement, 71% for the rigor of development, 100% for clarity of presentation, 43% for applicability, 100% for editorial independence, and 64% for overall assessment. CPG developers would benefit from the use of a standardized approach to the development of CPGs and use the contents of the AGREE II tool to improve the methodological rigor, reporting, and applicability of CPGs.
More Related Videos
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VII: Nursing Interventions
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure II: Pathophysiology
Heart Failure V: Medical Management